{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T12:35:24Z","timestamp":1776947724887,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00381-024-06329-4","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T08:32:07Z","timestamp":1710318727000},"page":"1671-1680","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nimotuzumab-vinorelbine combination therapy versus other regimens in the treatment of pediatric diffuse intrinsic pontine glioma"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1181-8169","authenticated-orcid":false,"given":"Ay\u015fe","family":"\u00d6zkan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1316-4501","authenticated-orcid":false,"given":"Beg\u00fcl","family":"Ya\u011fc\u0131 K\u00fcpeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7271-1803","authenticated-orcid":false,"given":"Serhan","family":"K\u00fcpeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2396-5692","authenticated-orcid":false,"given":"G\u00fclay","family":"Sezgin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0330-4766","authenticated-orcid":false,"given":"\u0130brahim","family":"Bayram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,13]]},"reference":[{"issue":"1","key":"6329_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics. CA Cancer J Clin 72(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21708","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 4","key":"6329_CR2","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","volume":"25","author":"QT Ostrom","year":"2023","unstructured":"Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS (2023) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016\u20132020. Neuro Oncol 25(Suppl 4):iv1\u2013iv99. https:\/\/doi.org\/10.1093\/neuonc\/noad149","journal-title":"Neuro Oncol"},{"issue":"6","key":"6329_CR3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization Classification of Tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"issue":"6","key":"6329_CR4","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1227\/00006123-199312000-00010","volume":"33","author":"AL Albright","year":"1993","unstructured":"Albright AL, Packer RJ, Zimmerman R, Rorke LB, Boyett J, Hammond GD (1993) Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children\u2019s Cancer Group. Neurosurgery 33(6):1026\u20131030. https:\/\/doi.org\/10.1227\/00006123-199312000-00010","journal-title":"Neurosurgery"},{"issue":"1","key":"6329_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11060-019-03271-3","volume":"145","author":"AS Chi","year":"2019","unstructured":"Chi AS, Tarapore RS, Hall MD, Shonka N, Gardner S, Umemura Y, Sumrall A, Khatib Z, Mueller S, Kline C, Zaky W, Khatua S, Weathers SP, Odia Y, Niazi TN, Daghistani D, Cherrick I, Korones D, Karajannis MA, Kong XT, Minturn J, Waanders A, Arillaga-Romany I, Batchelor T, Wen PY, Merdinger K, Schalop L, Stogniew M, Allen JE, Oster W, Mehta MP (2019) Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201. J Neurooncol 145(1):97\u2013105. https:\/\/doi.org\/10.1007\/s11060-019-03271-3","journal-title":"J Neurooncol"},{"issue":"14","key":"6329_CR6","doi-asserted-by":"publisher","first-page":"175883592211136","DOI":"10.1177\/17588359221113693","volume":"6","author":"I Giovannoni","year":"2022","unstructured":"Giovannoni I, Carboni A, Rinelli M, Agolini E, Mackay A, Jones C, Chiesa S, Balducci M, Locatelli F, Mastronuzzi A (2022) Targeted therapy for pediatric diffuse intrinsic pontine glioma: a single-center experience. Ther Adv Med Oncol 6(14):17588359221113692. https:\/\/doi.org\/10.1177\/17588359221113693","journal-title":"Ther Adv Med Oncol"},{"key":"6329_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11060-013-1189-0","volume":"114","author":"S Jackson","year":"2013","unstructured":"Jackson S, Patay Z, Howarth R, Pai Panandiker AS, Onar-Thomas A, Gajjar A, Broniscer A (2013) Clinicoradiologic characteristics of long-term survivors of diffuse intrinsic pontine glioma. J Neurooncol 114:339\u2013344. https:\/\/doi.org\/10.1007\/s11060-013-1189-0","journal-title":"J Neurooncol"},{"issue":"9","key":"6329_CR8","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1097\/PAS.0b013e318294e817","volume":"37","author":"LY Ballester","year":"2013","unstructured":"Ballester LY, Wang Z, Shandilya S, Miettinen M, Burger PC, Eberhart CG, Rodriguez FJ, Raabe E, Nazarian J, Warren K, Quezado MM (2013) Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas. Am J Surg Pathol 37(9):1357\u20131364. https:\/\/doi.org\/10.1097\/PAS.0b013e318294e817","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"6329_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1517\/14712598.2011.546341","volume":"11","author":"M Massimino","year":"2011","unstructured":"Massimino M, Bode U, Biassoni V, Fleischhack G (2011) Nimotuzumab for pediatric diffuse intrinsic pontine gliomas. Expert Opin Biol Ther 11(2):247\u2013256. https:\/\/doi.org\/10.1517\/14712598.2011.546341","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"6329_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11060-014-1428-z","volume":"118","author":"M Massimino","year":"2014","unstructured":"Massimino M, Biassoni V, Miceli R, Schiavello E, Warmuth-Metz M, Modena P, Casanova M, Pecori E, Giangaspero F, Antonelli M, Buttarelli FR, Potepan P, Pollo B, Nunziata R, Spreafico F, Podda M, Anichini A, Clerici CA, Sardi I, De Cecco L, Bode U, Bach F, Gandola L (2014) Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood. J Neuro-Oncol 118(2):305\u2013312. https:\/\/doi.org\/10.1007\/s11060-014-1428-z","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"6329_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11060-019-03140-z","volume":"143","author":"G Fleischhack","year":"2019","unstructured":"Fleischhack G, Massimino M, Warmuth-Metz M, Khuhlaeva E, Janssen G, Graf N, Rutkowski S, Beilken A, Schmid I, Biassoni V, Gorelishev SK, Kramm C, Reinhard H, Schlegel PG, Kortmann RD, Reuter D, Bach F, Iznaga-Escobar NE, Bode U (2019) Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study. J Neurooncol 143(1):107\u2013113. https:\/\/doi.org\/10.1007\/s11060-019-03140-z","journal-title":"J Neurooncol"},{"issue":"1","key":"6329_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/cncr.20741","volume":"103","author":"A Broniscer","year":"2005","unstructured":"Broniscer A, Iacono L, Chintagumpala M, Fouladi M, Wallace D, Bowers DC, Stewart C, Krasin MJ, Gajjar A (2005) Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98). Cancer 103(1):133\u2013139. https:\/\/doi.org\/10.1002\/cncr.20741","journal-title":"Cancer"},{"issue":"4","key":"6329_CR13","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00381-012-2013-4","volume":"29","author":"D Aguilera","year":"2013","unstructured":"Aguilera D, Mazewski C, Fangusaro J, MacDonald TJ, McNall-Knapp RY, Hayes LL, Kim S, Castellino RC (2013) Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: a multi-institutional experience. Childs Nerv Syst 29(4):589\u2013596. https:\/\/doi.org\/10.1007\/s00381-012-2013-4","journal-title":"Childs Nerv Syst"},{"issue":"18","key":"6329_CR14","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1016\/j.ejca.2010.07.005","volume":"46","author":"JR Geyer","year":"2010","unstructured":"Geyer JR, Stewart CF, Kocak M, Broniscer A, Phillips P, Douglas JG, Blaney SM, Packer RJ, Gururangan S, Banerjee A, Kieran MW, Kun LE, Gilbertson RJ, Boyett JM (2010) A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas. Eur J Cancer 46(18):3287\u20133293. https:\/\/doi.org\/10.1016\/j.ejca.2010.07.005","journal-title":"Eur J Cancer"},{"issue":"8","key":"6329_CR15","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1200\/JCO.2003.05.116","volume":"21","author":"Taylor RE, Bailey CC, Robinson K, Weston CL, Ellison D, Ironside J, Lucraft H, Gilbertson R, Tait DM, Walker DA, Pizer BL, Imeson J, Lashford LS; International Society of Paediatric Oncology; United Kingdom Children\u2019s Cancer Study Group","year":"2003","unstructured":"Taylor RE, Bailey CC, Robinson K, Weston CL, Ellison D, Ironside J, Lucraft H, Gilbertson R, Tait DM, Walker DA, Pizer BL, Imeson J, Lashford LS; International Society of Paediatric Oncology; United Kingdom Children\u2019s Cancer Study Group (2003) Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology\/United Kingdom Children\u2019s Cancer Study Group PNET-3 Study. J Clin Oncol 21(8):1581\u20131591. https:\/\/doi.org\/10.1200\/JCO.2003.05.116","journal-title":"J Clin Oncol"},{"issue":"6","key":"6329_CR16","doi-asserted-by":"publisher","first-page":"e330","DOI":"10.1016\/S1470-2045(20)30166-2","volume":"21","author":"TM Cooney","year":"2020","unstructured":"Cooney TM, Cohen KJ, Guimaraes CV, Dhall G, Leach J, Massimino M, Erbetta A, Chiapparini L, Malbari F, Kramer K, Pollack IF, Baxter P, Laughlin S, Patay Z, Young Poussaint T, Warren KE (2020) Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. Lancet Oncol 21(6):e330\u2013e336. https:\/\/doi.org\/10.1016\/S1470-2045(20)30166-2","journal-title":"Lancet Oncol"},{"key":"6329_CR17","unstructured":"National Cancer Institute. Common terminology criteria for adverse events v3.0 (CTCAE) (2006) Available at https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcaev3.pdf. Accessed 15 Jan 2024"},{"key":"6329_CR18","unstructured":"https:\/\/www.ibm.com\/support\/pages\/how-cite-ibm-spss-statistics-or-earlier-versions-spss"},{"issue":"1","key":"6329_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/ped.14070","volume":"62","author":"A Hayashi","year":"2020","unstructured":"Hayashi A, Ito E, Omura M, Aida N, Tanaka M, Tanaka Y, Sato H, Miyagawa N, Yokosuka T, Iwasaki F, Hamanoue S, Goto H (2020) Hypofractionated radiotherapy in children with diffuse intrinsic pontine glioma. Pediatr Int 62(1):47\u201351. https:\/\/doi.org\/10.1111\/ped.14070","journal-title":"Pediatr Int"},{"key":"6329_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3389\/fonc.2015.00237","volume":"5","author":"MI Vanan","year":"2015","unstructured":"Vanan MI, Eisenstat DD (2015) DIPG in children \u2013 what can we learn from the past? Front Oncol 5:237. https:\/\/doi.org\/10.3389\/fonc.2015.00237","journal-title":"Front Oncol"},{"key":"6329_CR21","unstructured":"K\u00fcpeli S, Yal\u00e7\u0131n B, Zorlu F, Akalan N, Ya\u011fc\u0131 B, Varan A, Akyuz C, Buyukpamukcu M (2009) Pontine gliomas in children: experience of a single center. 8th INCTR Meeting on Cancer in Countries with Limited Resources, March 2009, Antalya, Turkey, Abstract Book,  pp 85."},{"issue":"1","key":"6329_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00381-018-4001-9","volume":"35","author":"R Kebudi","year":"2019","unstructured":"Kebudi R, Cakir FB, Bay SB, Gorgun O, Alt\u0131nok P, Iribas A, Agaoglu FY, Darendeliler E (2019) Nimotuzumab-containing regimen for pediatric diffuse intrinsic pontine gliomas: a retrospective multicenter study and review of the literature. Child\u2019s Nerv Syst 35(1):83\u201389. https:\/\/doi.org\/10.1007\/s00381-018-4001-9","journal-title":"Child\u2019s Nerv Syst"},{"issue":"8","key":"6329_CR23","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s00210-021-02109-y","volume":"394","author":"H Susam-Sen","year":"2021","unstructured":"Susam-Sen H, Varan A, Bajin \u0130, G\u00f6\u00e7men R, Ayd\u0131n B, Yalcin B, Kurucu N, Kutluk T, Bayhan T, Akyuz C (2021) Nimotuzumab therapy in the treatment of pediatric central nervous system tumors: single-center experience. Naunyn Schmiedebergs Arch Pharmacol 394(8):1769\u20131777. https:\/\/doi.org\/10.1007\/s00210-021-02109-y","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"19","key":"6329_CR24","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2017.75.9308","volume":"36","author":"LM Hoffman","year":"2018","unstructured":"Hoffman LM, Veldhuijzen van Zanten SEM, Colditz N, Baugh J, Chaney B, Hoffmann M, Lane A, Fuller C, Miles L, Hawkins C, Bartels U, Bouffet E, Goldman S, Leary S, Foreman NK, Packer R, Warren KE, Broniscer A, Kieran MW, Minturn J, Comito M, Broxson E, Shih CS, Khatua S, Chintagumpala M, Carret AS, Escorza NY, Hassall T, Ziegler DS, Gottardo N, Dholaria H, Doughman R, Benesch M, Drissi R, Nazarian J, Jabado N, Boddaert N, Varlet P, Giraud G, Castel D, Puget S, Jones C, Hulleman E, Modena P, Giagnacovo M, Antonelli M, Pietsch T, Gielen GH, Jones DTW, Sturm D, Pfister SM, Gerber NU, Grotzer MA, Pfaff E, von Bueren AO, Hargrave D, Solanki GA, Jadrijevic Cvrlje F, Kaspers GJL, Vandertop WP, Grill J, Bailey S, Biassoni V, Massimino M, Calmon R, Sanchez E, Bison B, Warmuth-Metz M, Leach J, Jones B, van Vuurden DG, Kramm CM, Fouladi M (2018) Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): a collaborative report from the International and European Society for Pediatric Oncology DIPG Registries. J Clin Oncol 36(19):1963\u20131972. https:\/\/doi.org\/10.1200\/JCO.2017.75.9308","journal-title":"J Clin Oncol"},{"issue":"4","key":"6329_CR25","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/neuonc\/noq205","volume":"13","author":"KJ Cohen","year":"2011","unstructured":"Cohen KJ, Heideman RL, Zhou T, Holmes EJ, Lavey RS, Bouffet E, Pollack IF (2011) Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children\u2019s Oncology Group. Neuro Oncol 13(4):410\u2013416. https:\/\/doi.org\/10.1093\/neuonc\/noq205","journal-title":"Neuro Oncol"},{"issue":"4","key":"6329_CR26","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","volume":"32","author":"A Mackay","year":"2017","unstructured":"Mackay A, Burford A, Carvalho D, Izquierdo E, Fazal-Salom J, Taylor KR, Bjerke L, Clarke M, Vinci M, Nandhabalan M, Temelso S, Popov S, Molinari V, Raman P, Waanders AJ, Han HJ, Gupta S, Marshall L, Zacharoulis S, Vaidya S, Mandeville HC, Bridges LR, Martin AJ, Al-Sarraj S, Chandler C, Ng HK, Li X, Mu K, Trabelsi S, Brahim DH, Kisljakov AN, Konovalov DM, Moore AS, Carcaboso AM, Sunol M, de Torres C, Cruz O, Mora J, Shats LI, Stavale JN, Bidinotto LT, Reis RM, Entz-Werle N, Farrell M, Cryan J, Crimmins D, Caird J, Pears J, Monje M, Debily MA, Castel D, Grill J, Hawkins C, Nikbakht H, Jabado N, Baker SJ, Pfister SM, Jones DTW, Fouladi M, von Bueren AO, Baudis M, Resnick A, Jones C (2017) Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell 32(4):520-537.e5. https:\/\/doi.org\/10.1016\/j.ccell.2017.08.017","journal-title":"Cancer Cell"},{"issue":"7","key":"6329_CR27","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1158\/1078-0432.CCR-04-2045","volume":"11","author":"MS Bobola","year":"2005","unstructured":"Bobola MS, Silber JR, Ellenbogen RG, Geyer JR, Blank A, Goff RD (2005) O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines. Clin Cancer Res 11(7):2747\u20132755. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-2045","journal-title":"Clin Cancer Res"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-024-06329-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00381-024-06329-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-024-06329-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T10:05:30Z","timestamp":1716372330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00381-024-06329-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,13]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["6329"],"URL":"https:\/\/doi.org\/10.1007\/s00381-024-06329-4","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,13]]},"assertion":[{"value":"5 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Each author listed on the manuscript has seen and approved the submission of this version of the manuscript and takes full responsibility for the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"We confirm that there are no prior publications or submissions with any overlapping information.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}